The following discussion of our consolidated results of operations and cash
flows for the six months ended June 30, 2021 and 2020, and consolidated
financial conditions as of June 30, 2021 and December 31, 2020 should be read in
conjunction with our unaudited consolidated financial statements and the related
notes included elsewhere in this document.



Overview



We are a major grower and seller of yew trees and manufacturer of products made
from yew trees, we also sell branches and leaves of yew trees for the
manufacture of TCM containing taxol, which TCM has been approved in the PRC for
use as a secondary treatment of certain cancers, meaning it must be administered
in combination with other pharmaceutical drugs. The yew industry is highly
regulated in the PRC because the Northeast yew tree is considered an endangered
species. In the third quarter of 2016, we started to sell handmade yew essence
oil soaps and candles.



We operated in two reportable business segments. The business of HDS, JSJ, HYF
and YBT in PRC was managed and reviewed as PRC segment. The business of YBP, Yew
Bio-Pharm (HK), and MC was managed and reviewed as USA segment.



For the three months ended June 30, 2021 and 2020, revenues from the PRC segment
accounted for approximately 99.91% and 99.999%, respectively, of consolidated
revenue; revenues from USA segment accounted for approximately 0.09% and 0.001%
of consolidated revenue.



For the six months ended June 30, 2021 and 2020, revenues from the PRC segment
accounted for approximately 99.94% and 99.81%, respectively, of consolidated
revenue; revenues from USA segment accounted for approximately 0.06% and 0.19%
of consolidated revenue.



YBP's revenues were mostly generated by HDS and in the PRC. The expenses
incurred in the U.S. were primarily related to fulfilling the reporting
requirements of public listed company, stock-based compensation, office daily
operations and other costs. As of June 30, 2021, YBP had $5,414 in cash and held
the 100% equity interests in its subsidiaries Yew HK and JSJ. Yew HK itself has
no business operations or assets other than holding of equity interests in JSJ.
JSJ has no business operations and assets with a book value of approximately
$9,115, including approximately $9,115 in cash on June 30, 2021. JSJ also holds
the VIE interests in HDS through the contractual arrangements (the "Contractual
Arrangements") described in Notes to Unaudited Consolidated Financial
Statements. On November 4, 2014, HDS established a new subsidiary, Harbin Yew
Food Co. LTD. ("HYF"), to develop and cultivate wood ear mushroom drink. As of
June 30, 2021, HYF had started pilot production with a limited amount of sales.
On December 24, 2020, HDS acquired 80% ownership of a new subsidiary, Yew
(Guangzhou) Bio-Technology Co., Ltd ("YBT"), to marketing and sell cosmetics. As
of June 30, 2021, YBT had not started sales. In the event that we are unable to
enforce the Contractual Agreements, we may not be able to exert effective
control over HDS, HYF and YBT, and our ability to conduct our business may be
materially and adversely affected. If the applicable PRC authorities invalidate
our Contractual Agreements for any violation of PRC laws, rules and regulations,
we would lose control of the VIE and its subsidiary resulting in its
deconsolidation in financial reporting and severe loss in our market valuation.
On June 8, 2016, YBP established a new subsidiary, MC Commerce Holding Inc.
(MC), to sales the Company's yew products in American market. MC had limited
operation activities for the six months ended June 30, 2021.



In December 2019, COVID-19 was reported in China. Since then, COVID-19 has
spread globally, to include the United States and several European countries.
Many countries around the world have imposed quarantines and restrictions on
travel and mass gatherings to slow the spread of the virus and have closed
non-essential businesses. The pandemics could result in increased travel
restrictions, market downturns and changes in the behavior of the terminal
customers of our products related to pandemic fears. In addition, our certain
customers could decrease the demand on our products due to the outbreak of the
COVID-19. To date, our business is impact by the outbreak of the coronavirus
(COVID-19) in China. The extent to which the coronavirus impacts our results
will depend on future developments and reactions in China, which are highly
uncertain and will include emerging information concerning the severity of the
coronavirus and the actions taken by governments to attempt to contain the
coronavirus. Any decreased collectability of accounts receivable, or reduction
of purchase orders could further negatively impact our results of operations.



Critical accounting policies and estimates





Our discussion and analysis of our financial condition and results of operations
are based upon our consolidated financial statements, which have been prepared
in accordance with accounting principles generally accepted in the United
States. The preparation of these consolidated financial statements requires us
to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets
and liabilities. We continually evaluate our estimates, including those related
to bad debts, allowance for obsolete inventory, and the classification of short
and long-term inventory, the useful life of property and equipment and land use
rights and yew forest assets, recovery of long-lived assets, write-down in value
of inventory, and the valuation of equity transactions. We base our estimates on
historical experience and on various other assumptions that we believed to be
reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Any future changes to these estimates
and assumptions could cause a material change to our reported amounts of
revenues, expenses, assets and liabilities. Actual results may differ from these
estimates under different assumptions or conditions. We believe the following
critical accounting policies affect our significant judgments and estimates used
in the preparation of the financial statements.



21






Variable interest entities



Pursuant to ASC 810 and related subtopics related to the consolidation of
variable interest entities, we are required to include in our consolidated
financial statements the financial statements of VIEs. The accounting standards
require a VIE to be consolidated by a company if that company is subject to the
risk of loss for the VIE or is entitled to receive the VIE's residual returns.
VIEs are those entities in which we, through contractual arrangements, bear the
risk of, and enjoy the rewards normally associated with ownership of the entity,
and therefore we are the primary beneficiary of the entity. HDS is considered a
VIE, and we are the primary beneficiary. We entered into agreements with HDS
pursuant to which we shall receive 100% of HDS's net income. In accordance with
these agreements, HDS shall pay consulting fees equal to 100% of its net income
to our wholly-owned subsidiary, JSJ. JSJ shall supply the technology and
administrative services needed to service the HDS.



The accounts of HDS are consolidated in the accompanying financial statements.
As a VIE, HDS' sales are included in our total sales, its income from operations
is consolidated with ours, and our net income includes all of HDS' net income,
and their assets and liabilities are included in our consolidated balance
sheets. The VIEs do not have any non-controlling interest and, accordingly, we
did not subtract any net income in calculating the net income attributable to
us. Because of the contractual arrangements, we have pecuniary interest in HDS
that requires consolidation of HDS' financial statements with our financial
statements.



As required by ASC 810-10, we perform a qualitative assessment to determine
whether we are the primary beneficiary of HDS which is identified as a VIE of
us. A quality assessment begins with an understanding of the nature of the risks
in the entity as well as the nature of the entity's activities including terms
of the contracts entered into by the entity, ownership interests issued by the
entity and the parties involved in the design of the entity. The significant
terms of the agreements between us and HDS are discussed above in the "Corporate
Structure and Recapitalization - Second Restructure" section. Our assessment on
the involvement with HDS reveals that we have the absolute power to direct the
most significant activities that impact the economic performance of HDS. JSJ,
our wholly own subsidiary, is obligated to absorb the risk of loss from HDS
activities and is entitled to receive HDS's expected residual returns. In
addition, HDS' shareholders have pledged their equity interest in HDS to JSJ,
irrevocably granted JSJ an exclusive option to purchase, to the extent permitted
under PRC Law, all or part of the equity interests in HDS and agreed to entrust
all the rights to exercise their voting power to the person(s) appointed by JSJ.
Under the accounting guidance, we are deemed to be the primary beneficiary of
HDS and the results of HDS' operation are consolidated in our consolidated
financial statements for financial reporting purposes.



Accordingly, as a VIE, HDS' sales are included in our total sales, its income
from operations is consolidated with our income from operations and our net
income includes all of HDS' net income. All the equity (net assets) and profits
(losses) of HDS are attributed to us. Therefore, no non-controlling interest in
HDS is presented in our consolidated financial statements. As we do not have any
non-controlling interest and, accordingly, did not subtract any net income in
calculating the net income attributable to us. Because of the Contractual
Arrangements, YBP has a pecuniary interest in HDS that requires consolidation of
HDS' financial statements with those of ours.



Additionally, pursuant to ASC 805, as YBP and HDS are under the common control
of the HDS Shareholders, the Second Restructure was accounted for in a manner
similar to a pooling of interests. As a result, our historical amounts in the
accompanying consolidated financial statements give retrospective effect to the
Second Restructure, whereby our assets and liabilities are reflected at the
historical carrying values and their operations are presented as if they were
consolidated for all periods presented, with our results of operations being
consolidated from the date of the Second Transfer Agreement. The accounts of HDS
are consolidated in the accompanying financial statements.



Accounts receivable



Accounts receivable are presented net of an allowance for doubtful accounts. We
maintain allowances for doubtful accounts for estimated losses. We review the
accounts receivable balance on a periodic basis and make general and specific
allowances when there is doubt as to the collectability of individual balances.
In evaluating the collectability of individual receivable balances, we consider
many factors, including the age of the balance, a customer's historical payment
history, its current credit-worthiness and current economic trends. Accounts are
written off after exhaustive efforts at collection. We recognize the probability
of the collection for each customer.



Inventories



Inventories consisted of raw materials, work-in-progress, finished
goods-handicrafts, yew seedlings, yew candles and other trees (consisting of
larix, spruce and poplar trees). We classify our inventories based on our
historical and anticipated levels of sales; any inventory in excess of its
normal operating cycle of one year is classified as long-term on our
consolidated balance sheets. Inventories are stated at the lower of cost or
market value utilizing the weighted average method. Raw materials primarily
include yew timber used in the production of products such as handicrafts,
furniture and other products containing yew timber. Finished goods-handicraft
and yew seedlings include direct materials and direct labor.



We estimate the amount of the excess inventories by comparing inventory on hand
with the estimated sales that can be sold within our normal operating cycle of
one year. Any inventory in excess of our current requirements based on
historical and anticipated levels of sales is classified as long-term on our
consolidated balance sheets. Our classification of long-term inventory requires
us to estimate the portion of inventory that can be realized over the next

12
months.



22






To estimate the amount of slow-moving or obsolete inventories, we analyze
movement of our products, monitor competing products and technologies and
evaluate acceptance of our products. Periodically, we identify inventories that
cannot be sold at all or can only be sold at deeply discounted prices. An
allowance will be established if management determines that certain inventories
may not be saleable. If inventory costs exceed expected market value due to
obsolescence or quantities in excess of expected demand, we will record reserves
for the difference between the carrying cost and the estimated market value.



Our handicraft and yew furniture products are hand-made by traditional Chinese artisans.





In accordance with ASC 905, "Agriculture", our costs of growing yew seedlings
are accumulated until the time of harvest and are reported at the lower of

cost
or market.



Property and equipment



Property and equipment are carried at cost and are depreciated on a
straight-line basis (after taking into account their respective estimated
residual value) over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and
improvements are capitalized. When assets are retired or disposed of, the cost
and accumulated depreciation are removed from the accounts, and any resulting
gains or losses are included in income in the year of disposition. We examine
the possibility of decreases in the value of fixed assets when events or changes
in circumstances reflect the fact that their recorded value may not be
recoverable. The estimated useful lives are as follows:



Building                  10 - 20 years
Machinery and equipment    3 - 10 years
Office equipment            2 - 5 years
Motor vehicles             4 - 10 years



Land use rights and yew forest assets





All land in the PRC is owned by the PRC government and cannot be sold to any
individual or company. We have recorded the amounts paid to the PRC government
to acquire long-term interests to utilize land and yew forests as land use
rights and yew forest assets. This type of arrangement is common for the use of
land in the PRC. Yew trees on land containing yew tree forests are used to
supply raw materials such as branches, leaves and fruit to us that will be used
to manufacture our products. We amortize these land and yew forest use rights
over the term of the respective land and yew forest use right, which ranges from
15 to 50 years. The lease agreements do not have any renewal option and we have
no further obligations to the lessor. We record the amortization of these land
and forest use rights as part of our cost of revenues.



Revenue recognition



We generate our revenue from sales of yew seedling products, sales of yew raw
materials for medical application, sales of yew handicraft products, sales of
"Others" including yew candles, yew essential oil soap, pine needle extract,
complex taxus cuspidate extract, and composite northeast yew extract. Pursuant
to the guidance of ASC 606, we recognize revenue when obligations under the
terms of a contract with customer are satisfied; generally this occurs with the
transfer of control of the products sold. Transfer of control to the customer is
based on the standardized shipping terms in the contract as this determines when
we has the right to payment, the customer has legal title to the asset and the
customer has the risks of ownership.



Income taxes



We are governed by the Income Tax Law of the PRC, Hong Kong and the United
States. We account for income tax using the liability method prescribed by ASC
740, "Income Taxes". Under this method, deferred tax assets and liabilities are
determined based on the difference between the financial reporting and tax bases
of assets and liabilities using enacted tax rates that will be in effect in the
year in which the differences are expected to reverse. We record a valuation
allowance to offset deferred tax assets if based on the weight of available
evidence; it is more-likely-than-not that some portion, or all, of the deferred
tax assets will not be realized. The effect on deferred taxes of a change in tax
rates is recognized as income or loss in the period that includes the enactment
date.



We apply the provisions of ASC 740-10-50, "Accounting for Uncertainty in Income
Taxes", which provides clarification related to the process associated with
accounting for uncertain tax positions recognized in our financial statements.
Audit periods remain open for review until the statute of limitations has
passed. The completion of review or the expiration of the statute of limitations
for a given audit period could result in an adjustment to our liability for
income taxes. Any such adjustment could be material to our results of operations
for any given quarterly or annual period based, in part, upon the results of
operations for the given period. Currently, we have no uncertain tax positions,
and will continue to evaluate for uncertain positions in the future.



23






Stock-based compensation



Stock based compensation is accounted for based on the requirements of the
Share-Based Payment topic of ASC 718 which requires recognition in the financial
statements of the cost of employee and director services received in exchange
for an award of equity instruments over the period the employee or director is
required to perform the services in exchange for the award. The Accounting
Standards Codification also requires measurement of the cost of employee and
director services received in exchange for an award based on the grant-date

fair
value of the award.



The Company accounts for share-based compensation awards to nonemployees in
accordance with FASB ASC 718 and FASB ASC 505-50. Under FASB ASC 718 and FASB
ASC 505-50, stock compensation granted to non-employees has been determined as
the fair value of the consideration received or the fair value of equity
instrument issued, whichever is more reliably measured and is recognized as an
expense as the goods or services are received.



Recent accounting pronouncements


In February 2016, the Financial Accounting Standards Board ("FASB") issued new
leasing guidance ("Topic 842") that replaced the existing lease guidance ("Topic
840"). Topic 842 established a right-of-use ("ROU") model that requires a lessee
to record a ROU asset and lease liability on the balance sheet for all leases
with terms longer than 12 months. Leases are classified as either finance or
operating, with classification affecting the pattern of expense recognition in
the statement of operations. This guidance also expanded the requirements for
lessees to record leases embedded in other arrangements and the required
quantitative and qualitative disclosures surrounding leases.



The Company adopted Topic 842 on its effective date of January 1, 2019 using a
modified retrospective transition approach; as such, Topic 842 will not be
applied to periods prior to adoption and the adoption had no impact on the
Company's previously reported results. The Company elected the package of
practical expedients permitted under the transition guidance within Topic 842,
which allowed the Company to carry forward its identification of contracts that
are or contain leases, its historical lease classification and its accounting
for initial direct costs for existing leases. The impact of adopting Topic 842
was not material to the Company's result of operations or cash flows for the six
months ended June 30, 2021. The Company recognized operating lease liabilities
of $350,000 upon adoption, with corresponding ROU assets on its balance sheet.



Currency exchange rates



Our functional currency is the U.S. dollar, and the functional currency of our
operating subsidiaries and VIE is the RMB. All of our sales are denominated in
RMB. As a result, changes in the relative values of U.S. dollars and RMB affect
our reported levels of revenues and profitability as the results of our
operations are translated into U.S. dollars for reporting purposes. In
particular, fluctuations in currency exchange rates could have a significant
impact on our financial stability due to a mismatch among various foreign
currency-denominated sales and costs. Fluctuations in exchange rates between the
U.S. dollar and RMB affect our gross and net profit margins and could result in
foreign exchange and operating losses.



Our exposure to foreign exchange risk primarily relates to currency gains or
losses resulting from timing differences between signing of sales contracts and
settling of these contracts. Furthermore, we translate monetary assets and
liabilities denominated in other currencies into RMB, the functional currency of
our operating subsidiaries. Our results of operations and cash flow are
translated at average exchange rates during the period, and assets and
liabilities are translated at the unified exchange rate at the end of the
period. Translation adjustments resulting from this process are included in
accumulated other comprehensive income in our statement of shareholders' equity.
We have not used any forward contracts, currency options or borrowings to hedge
our exposure to foreign currency exchange risk. We cannot predict the impact of
future exchange rate fluctuations on our results of operations and may incur net
foreign currency losses in the future.



Our financial statements are expressed in U.S. dollars, which is the functional
currency of our parent company. The functional currency of our operating
subsidiaries and affiliates is RMB. To the extent we hold assets denominated in
U.S. dollars, any appreciation of the RMB against the U.S. dollar could result
in a charge in our statement of operations and a reduction in the value of our
U.S. dollar denominated assets. On the other hand, a decline in the value of RMB
against the U.S. dollar could reduce the U.S. dollar equivalent amounts of

our
financial results.



24






Results of Operations



The following tables set forth key components of our results of operations for
the periods indicated, in dollars. The discussion following the table is based
on these results:



                                                Three Months Ended                Six Months Ended
                                                     June 30,                         June 30,
                                               2021            2020             2021             2020
Revenues - third parties                   $  6,804,717     $   159,709     $  6,805,262     $    181,498
Revenues - related parties                    8,038,852       9,402,448       16,775,621       11,409,841
Total revenues                               14,843,569       9,562,157       23,580,883       11,591,339

Cost of revenues - third parties              6,932,631         341,204        6,945,631          382,570
Cost of revenues - related parties            8,138,966       7,935,570       15,906,307        9,481,131
Total cost of revenues                       15,071,597       8,276,774    

  22,851,938        9,863,701
Gross profit                                   (228,028 )     1,285,383          728,945        1,727,638
Operating expenses                              202,613         428,883       (1,807,121 )        713,750

Income from operations                         (430,641 )       856,500        2,536,066        1,013,888
Other expenses, net                            (115,097 )      (118,933 )  

    (169,838 )       (124,909 )
Income taxes                                     (1,859 )             -           (1,859 )              -
Net income                                     (547,597 )       737,567        2,364,369          888,979
Other comprehensive income (loss):
Foreign currency translation adjustment         723,236         102,289          471,124         (713,755 )
Comprehensive income (loss)                $    175,639     $   839,856
$  2,835,493     $    175,224




25





Three and Six Months Ended June 30, 2021 Compared to Three and Six Months Ended June 30, 2020





Revenues



For the three months ended June 30, 2021, we had total revenues of $14,843,569,
as compared to $9,562,157 for the three months ended June 30, 2020, an increase
of $5,281,412 or 55.23%. The increase in total revenue was attributable to the
increase in revenues of extracts and TCM raw materials.



For the six months ended June 30, 2021, we had total revenues of $23,580,883, as
compared to $11,591,339, for the six months ended June 30, 2020, an increase of
$11,989,544 or 103.44%. The increase in total revenue was attributable to the
increase in revenues of extracts and TCM raw materials.



Total revenue is summarized as follows:





                         Three Months Ended
                              June 30,                Increase        Percentage
                        2021            2020         (Decrease)         Change
TCM raw materials   $  6,361,705     $ 5,076,245     $ 1,285,460            25.32 %
Handicrafts                    -               -               -                - %
Extracts               8,417,209       4,326,203       4,091,006            94.56
Others                    64,655         159,709         (95,054 )         (59.52 )%
Total               $ 14,843,569     $ 9,562,157     $ 5,281,412            55.23 %




                          Six Months Ended
                              June 30,                  Increase        Percentage
                        2021             2020          (Decrease)         Change
TCM raw materials   $  9,937,224     $  7,083,638     $  2,853,586            40.28 %
Handicrafts                    -                -                -                - %
Extracts              13,578,459        4,326,203        9,252,256           213.87
Others                    65,200          181,498         (116,298 )         (64.08 )%
Total               $ 23,580,883     $ 11,591,339     $ 11,989,544           103.44 %




For the three and six months ended June 30, 2021 compared to June 30, 2020, the
increase in extracts was mainly attributable to the increase in demand of pine
needle extract, complex taxus cuspidate extract, and composite northeast yew
extract. The increase in revenue of TCM raw material was mainly attributable to
the increase in demand from our related party, Yew Pharmaceutical.



Cost of Revenues



For the three months ended June 30, 2021, cost of revenues amounted to
$15,071,597 as compared to $8,276,774 for the three months ended June 30, 2020,
an increase of $6,794,823 or 82.10%. For the three months ended June 30, 2021,
cost of revenues accounted for 101.54% of total revenues compared to 86.56% of
total revenues for the three months ended June 30, 2020.



For the six months ended June 30, 2021, cost of revenues amounted to $22,851,938
as compared to $9,863,701 for the six months ended June 30, 2020, an increase of
$12,988,237 or 131.68%. For the six months ended June 30, 2021, cost of revenues
accounted for 96.91% of total revenues compared to 85.10% of total revenues for
the six months ended June 30, 2020.



26





Cost of revenues by product categories is as follows:





                         Three Months Ended
                              June 30,                Increase        Percentage
                        2021            2020         (Decrease)         Change
TCM raw materials   $  6,457,758     $ 3,873,423     $ 2,584,335            66.72 %
Handicrafts                    -               -               -                - %
Extracts               8,380,945       3,849,876       4,531,069           117.69
Others                   232,894         553,475        (320,581 )         (57.92 )%
Total               $ 15,071,597     $ 8,276,774     $ 6,794,823            82.10 %




                          Six Months Ended
                              June 30,                 Increase        Percentage
                        2021            2020          (Decrease)         Change
TCM raw materials   $  9,207,880     $ 5,569,307     $  3,638,573            65.33 %
Handicrafts                    -               -                -                - %
Extracts              13,398,164       3,849,876        9,548,288           248.02
Others                   245,894         444,518         (198,624 )         (44.68 )%
Total               $ 22,851,938     $ 9,863,701     $ 12,988,237           131.68 %




The increase in our cost of revenues for the three and six months ended June 30,
2021 as compared to the three months and six months ended June 30, 2020 was in
line with the increase in revenue.



Gross Profit



For the three months ended June 30, 2021, gross profit was $(228,028) as
compared to $1,285,383 for the three months ended June 30, 2020, representing
gross profit margins of (1.54)% and 13.44%, respectively. For the six months
ended June 30, 2021, gross profit was $728,945 as compared to $1,727,638 for the
six months ended June 30, 2020, representing gross profit margins of 3.09% and
14.90%, respectively. Gross profit margins by categories are as follows:



                                            Three Months Ended                               Six Months Ended
                                                 June 30,                                        June 30,
                                                               (Decrease)                                      (Decrease)
                                  2021           2020           Increase          2021           2020           Increase
TCM raw materials                   (1.51 )%       23.70 %          (25.21 )%        7.34 %        21.38 %          (14.04 )%
Handicrafts                             - %            - %               - %            - %            - %               - %
Extracts                             0.43 %        11.01 %          (10.58 )%        1.33 %        11.01 %           (9.68 )%
Others                            (260.21 )%     (246.55 )%         (13.66 )%     (277.14 )%     (114.92 )%        (132.22 )%
Total                               (1.54 )%       13.44 %          (14.98 )%        3.09 %        14.90 %          (11.81 )%



The decrease in our overall gross profit margin for the three and six month ended June 30, 2021 as compared to the three and six months ended June 30, 2020 were primarily attributable to the lower gross margin yields of TCM raw materials and extracts.





27






Operating Expenses


For the three months ended June 30, 2021, operating expenses amounted to $202,613, as compared to $428,883 for the three months ended June 30, 2020, a decrease of $226,270 or 52.76%. The decrease was mainly due to no bad debt expense occurred during the three months ended June 30, 2021, compares with $193,466 bad debt expense occurred during the three months ended June 30, 2020.





For the six months ended June 30, 2021, operating expenses amounted to
$(1,807,121) as compared to $713,750 for the six months ended June 30, 2020, a
decrease of $2,520,871 or 353.19%. The decrease was mainly due to the bad debt
recovery occurred during the six months ended June 30, 2021, compares with
$196,806 bad debt expense occurred during the six months ended June 30, 2020.



Income from Operations



For the three months ended June 30, 2021, income from operations was $(430,641),
as compared to income from operations of $856,500 for the three months ended
June 30, 2020, a decrease of $1,287,141, or 150.28%. The decrease was primarily
attributable to the decrease in gross profit from TCM raw materials and extracts
after offset by the decrease of bad debt expenses.



For the six months ended June 30, 2021, income from operations was $2,536,066,
as compared to income from operations of $1,013,888 for the six months ended
June 30, 2020, an increase of $1,522,178, or 150.13%. The increase was primarily
attributable to $2.2 million recovery of bad debt expenses after offset by the
decrease in gross profit from TCM raw materials and extracts.



Other Expenses



For the three months ended June 30, 2021, total other expense was $115,097 as
compared to total other expense of $118,933 for the three months ended June 30,
2020. The decrease was primarily attributable to the increase of other income,
partially offset by the increase of exchange loss.



For the six months ended June 30, 2021, total other expense was $169,838 as
compared to total other expense of $124,909 for the six months ended June 30,
2020. The decrease was primarily attributable to the increase of other income,
partially offset by the increase of exchange loss.



Net Income



As a result of the factors described above, our net loss was $(547,597) or
$(0.01) (basic and diluted), for the three months ended June 30, 2021, as
compared to net income of $737,567 or $0.01 (basic and diluted), for the three
months ended June 30, 2020. As a result of the factors described above, our net
income was $2,364,369 or $0.05 (basic and diluted), for the six months ended
June 30, 2021, as compared to net income of $888,979 or $0.02 (basic and
diluted), for the six months ended June 30, 2020.



Foreign Currency Translation Adjustment


For the three months ended June 30, 2021, we reported an unrealized gain on
foreign currency translation of $723,236, as compared to an unrealized gain of
$102,289 for the three months ended June 30, 2020. For the six months ended June
30, 2021, we reported an unrealized gain on foreign currency translation of
$471,124, as compared to an unrealized loss of $713,755 for the six months ended
June 30, 2020. The change reflects the effect of the value of the U.S. dollar in
relation to the RMB. As described elsewhere herein, the functional currency of
our subsidiary, JSJ, and our VIE, HDS, is the RMB. The accompanying consolidated
financial statements have been translated and presented in U.S. dollars using
period end rates of exchange for assets and liabilities, and average rates of
exchange for the period for net revenues, costs, and expenses. Net gains
resulting from foreign exchange transactions, if any, are included in the
consolidated statements of income and comprehensive income.



Comprehensive Income



For the three months ended June 30, 2021, comprehensive income of $175,639 was
derived from the sum of our net income of $(547,597) with foreign currency
translation gain of $723,236. For the three months ended June 30, 2021,
comprehensive income of $839,856 was derived from the sum of our net income of
$737,567 with foreign currency translation gain of $102,289.



For the six months ended June 30, 2021, comprehensive income of $2,835,493 was
derived from the sum of our net income of $2,364,369 with foreign currency
translation gain of $471,124. For the six months ended June 30, 2020,
comprehensive income of $175,224 was derived from the sum of our net income of
$888,979 with foreign currency translation loss of $713,755.



Segment Information



For the three and six months ended June 30, 2021 as compared to the three and
six months ended June 30, 2020, we operated in two reportable business segments.
The business of HDS, JSJ, HYF and YBT in PRC was managed and reviewed as PRC
segment. The business of YBP, Yew Bio-Pharm (HK), and MC was managed and
reviewed as USA segment.



28





Information with respect to these reportable business segments for the three months ended June 30, 2021 and 2020 was as follows:





                                                 For the three months                             For the three months
                                                    June 30, 2021                                     June 30, 2020
                                     Revenues-       Revenues -                        Revenues-       Revenues -
                                       third           related                           third          related
                                      parties           party            Total          parties          party            Total
Revenues:
PRC                                 $ 6,792,086     $   8,038,852     $ 14,830,938     $  159,655     $  9,402,448     $ 9,562,103

USA                                      12,631                 -           12,631             54                -              54

Total revenues                      $ 6,804,717     $   8,038,852     $ 14,843,569     $  159,709     $  9,402,448     $ 9,562,157

Information with respect to these reportable business segments for the six months ended June 30, 2021 and 2020 was as follows:





                                                 For the six months                                For the six months
                                                    June 30, 2021                                    June 30, 2020
                                     Revenues-       Revenues -                       Revenues-       Revenues -
                                       third          related                           third          related
                                      parties          party            Total          parties          party            Total

Revenues:
PRC                                 $ 6,792,086     $ 16,775,621     $ 23,567,707     $  159,655     $ 11,409,841     $ 11,569,496

USA                                      13,176                -           13,176         21,843                -           21,843

Total revenues                      $ 6,805,262     $ 16,775,621     $ 23,580,883     $  181,498     $ 11,409,841     $ 11,591,339
During the three months ended June 30, 2021 and 2020, the revenue from PRC
segment was $14,830,938 and $9,562,103, respectively, increase of $5,268,835 or
55.10% due to the increase demand on Asia market. The increase in PRC segment
was mainly due to the increase in revenue from third parties in the amount of
$6,632,431, offset by the decrease in revenue from related parties in the amount
of 1,363,596.



During the three months ended June 30, 2021 and 2020, the revenue from USA
segment was $12,631 and $54, respectively, increase of $12,577 or 23,290.74%.
The increase in USA segment was due to the increase in revenue from third
parties in the amount of $12,577 attributable to our China customers' increased
oversea demand.



During the six months ended June 30, 2021 and 2020, the revenue from PRC segment
was $23,567,707 and $11,569,496, respectively, increase of $11,998,211 or
103.71% due to the increase demand on Asia market. The increase in PRC segment
was mainly due to the increase in revenue from third parties in the amount of
$6,632,431, and the increase in revenue from related parties in the amount

of
5,365,780.



During the six months ended June 30, 2021 and 2020, the revenue from USA segment
was $13,176 and $21,843, respectively, decrease of $8,667 or 39.68%. The
decrease in USA segment was due to the decrease in revenue from third parties in
the amount of $8,667 attributable to our China customers' decreased oversea
demand.



Liquidity and Capital Resources





Liquidity is the ability of a company to generate funds to support its current
and future operations, satisfy its obligations and otherwise operate on an
ongoing basis. On June 30, 2021 and December 31, 2020, we had cash balances of
$166,931 and $563,792, respectively. These funds are primarily located in
various financial institutions located in China. Our primary uses of cash have
been for the purchase of yew trees, land use rights and yew forest assets.
Additionally, we use cash for employee compensation and working capital. Our
working capital increased by $7,559,173 to $7,023,447 on June 30, 2021, from
working capital of $(535,726) on December 31, 2020.



For the six months ended June 30, 2021, net cash flow provided by operating
activities was $1,036,171, as compared to net cash flow provided by operating
activities of $7,037,722 for the six months ended June 30, 2020, a decrease of
$6,001,551. Because the exchange rate conversion is different for the balance
sheet and the statements of cash flows, the changes in assets and liabilities
reflected on the statements of cash flows are not necessarily identical with the
comparable changes reflected on the balance sheets.



For the six months ended June 30, 2021, net cash flow provided by operating activities of $1,036,171 was primarily attributable to:

? net income of approximately $2,364,000 adjusted for the add-back of non-cash

items, such as bad debt recovery of approximately $2,300,000, amortization of

land use rights and yew forest assets of approximately $1,400,000, and sale of

yew forest assets as inventory of approximately 7,800,000; and

? changes in operating assets and liabilities, such as an increase in accounts


    receivable of approximately $2,500,000, and an increase in accounts
    receivable-related parties of approximately $5,700,000.




29

For the six months ended June 30, 2020, net cash flow provided by operating activities of $7,037,722 was primarily attributable to:

? net income of approximately $890,000 adjusted for the add-back of non-cash

items, such as inventory additional reserves of approximately $370,000, sale

of yew forest assets as inventory of approximately 4,300,000, amortization of

land use rights and yew forest assets of approximately $1,300,000 and bad debt

expense of approximately $200,000; and

? Changes in operating assets and liabilities, such as a decrease in accounts

receivable of approximately $3,400,000, an increase in accounts

receivable-related parties of approximately $4,400,000, and a decrease in


    inventories of approximately $830,000.




Net cash flow used in investing activities was $1,714,509 for the six months
ended June 30, 2021. During the six months ended June 30, 2021, our prepayment
in purchase of yew forest assets decreased by approximately $340,000. We also
have purchased approximately $1,300,000 yew forest assets. Net cash flow used in
investing activities was approximately $6,000,000 for the six months ended June
30, 2020. During the six months ended June 30, 2020, we have made payment in
approximately $5,00,000 for purchase of yew forest assets, and made prepayment
in approximately $600,000 for purchase of yew forest assets.



Net cash flow provided by financing activities was approximately $340,000 for
the six months ended June 30, 2021 due to proceeds of approximately $5,700,000
from short-term borrowings and partially offset by repayment of short-term
borrowings of approximately $5,400,000. Net cash flow provided by financing
activities was approximately $71,000 for the six months ended June 30, 2020 and
consisted of proceeds of $5,300,000 from banks, and offset by repayments of
approximately $5,200,000.



We have historically financed our operations and capital expenditures through
cash flows from operations, bank loans and advances from related parties. From
March 2008 to September 2009, we received approximately $2.9 million of proceeds
in the aggregate from offerings and sales of our common stock. Except for the
portion used to pay for professional and other expenses in the U.S., substantial
portions of the proceeds we received through sales of our common stock were
retained in the PRC and used to fund our working capital requirements. As the
PRC government imposes controls on PRC companies' ability to convert RMB into
foreign currencies and the remittance of currency out of China, from time to
time, in order to fund our corporate activities in the U.S., Zhiguo Wang, our
President and CEO, advanced funds to us in the U.S. and we repaid the amounts
owed to him in RMB in the PRC.



The majority of our funds are maintained in RMB in bank accounts in China. We
receive most of our revenue in the PRC. Under existing PRC foreign exchange
regulations, payments of current account items, including profit distributions,
interest payments and expenditures from trade related transactions, can be made
in foreign currencies by complying with certain procedural requirements.
However, approval from China's State Administration of Foreign Exchange ("SAFE")
or its local counterparts is required where RMB is to be converted into foreign
currency and remitted out of China to pay capital expenses such as the repayment
of loans denominated in foreign currencies. The PRC government may also, at its
discretion, restrict access to foreign currencies for current account
transactions. As of June 30, 2021 and December 31, 2020, approximately $53.5
million and $50.3 million, respectively, of our net assets are located in the
PRC. If the foreign exchange control system in the PRC prevents us from
obtaining sufficient foreign currency to satisfy our currency demands, we may
not be able to transfer funds deposited within the PRC to fund working capital
requirements in the U.S. or pay any dividends in currencies other than the

RMB,
to our shareholders..


Off-Balance Sheet Arrangements





We have not entered into any financial guarantees or other commitments to
guarantee the payment obligations of any third parties. We have not entered into
any derivative contracts that are indexed to our shares and classified as
shareholder's equity or that are not reflected in our consolidated financial
statements. Furthermore, we do not have any retained or contingent interest in
assets transferred to an unconsolidated entity that serves as credit, liquidity
or market risk support to such entity. We do not have any variable interest in
any unconsolidated entity that provides financing, liquidity, market risk or
credit support to us or engages in leasing, hedging or research and development
services with us.



30

© Edgar Online, source Glimpses